Celiac Panel: How to Interpret Your Results

What a Celiac Panel Actually Measures

A celiac panel is not a single test. It is a group of blood tests that together look for antibodies your immune system produces when gluten triggers an abnormal response in the small intestine. The goal is to screen for celiac disease, an autoimmune condition in which gluten consumption damages the intestinal lining and impairs nutrient absorption.

Each marker in the panel answers a slightly different question. Understanding what each one measures helps you read your report with confidence.

tTG-IgA (Tissue Transglutaminase IgA)

This is the cornerstone of every adult celiac screen. Your immune system makes tTG-IgA antibodies against the enzyme transglutaminase 2, which is found in your gut lining. Most guidelines, including those from the American College of Gastroenterology, list tTG-IgA as the preferred single test because it carries a sensitivity of approximately 95% and a specificity of approximately 95% in adults eating a gluten-containing diet.

A tTG-IgA result below the lab's upper limit of normal (typically <4 U/mL, but confirm with your own report) is considered negative. A value two to ten times the upper limit of normal suggests celiac disease. A value more than ten times the upper limit of normal has a positive predictive value high enough that European Society for Paediatric Gastroenterology guidelines now allow a biopsy-free diagnosis in children under those conditions, though adult guidelines still require biopsy confirmation.

Total Serum IgA

This companion test exists for one reason: to catch IgA deficiency. About 1 in 400 to 1 in 600 people have selective IgA deficiency, which means they cannot make IgA antibodies at all. If your total IgA is low, your tTG-IgA will be falsely negative even if you have celiac disease. A normal total IgA validates your tTG-IgA result. A low total IgA means the lab should instead run IgG-based tests (tTG-IgG or DGP-IgG).

DGP (Deamidated Gliadin Peptide) Antibodies, IgA and IgG

Gliadin is the protein fraction of gluten that triggers the immune response. Deamidated gliadin peptide antibodies are newer and more specific than the older anti-gliadin antibody tests. DGP-IgG is particularly useful when IgA deficiency is present and is also more sensitive than tTG-IgA in very young children. In adults, DGP tests add value when tTG-IgA results are borderline and clinical suspicion remains high.

EMA-IgA (Endomysial Antibody IgA)

EMA-IgA has a specificity close to 99%, meaning a positive result is highly reliable. The catch is that it is operator-dependent (read by a technician under a microscope) and more expensive. It is often used as a confirmatory reflex test when tTG-IgA is elevated, rather than as a first-line screen.

What Normal and Abnormal Results Mean for You

The word "normal" in lab work means within the reference range the lab established from its study population. It does not mean you are symptom-free, and it does not mean the test is perfect.

Negative Results

A negative tTG-IgA with a normal total IgA makes celiac disease unlikely. If you are already eating gluten-free before the test, however, your antibodies may have normalized and a true positive result can be missed. Testing requires active gluten consumption for at least 6 weeks before the blood draw. This is one of the most common reasons a panel returns negative in someone who actually has celiac disease.

A negative panel does not rule out non-celiac gluten sensitivity (NCGS), which does not produce the same antibodies and has no validated biomarker.

Borderline or Weakly Positive Results

A result slightly above the upper limit of normal is the most difficult to interpret. Studies suggest that low-positive tTG-IgA values (1-3 times the upper limit of normal) may reflect conditions other than celiac disease, including type 1 diabetes, inflammatory bowel disease, liver disease, and heart failure. Retesting after three to six months of continued gluten intake, adding EMA-IgA, and referring to gastroenterology are all reasonable next steps.

High Positive Results

A tTG-IgA more than ten times the upper limit of normal, combined with symptoms (chronic diarrhea, iron-deficiency anemia that does not respond to oral iron, bloating, or unexplained infertility), strongly suggests celiac disease. A small-bowel biopsy remains the standard of care for adults to confirm the diagnosis and grade the degree of intestinal damage using the Marsh classification system.

Why Women Are Diagnosed Differently

Celiac disease is not a gender-neutral condition. Women make up approximately 60-70% of diagnosed cases, and the reasons go beyond healthcare-seeking behavior.

Hormonal Amplification of Autoimmunity

Estrogen generally amplifies immune responses and promotes antibody production, which may explain why autoimmune diseases including celiac disease disproportionately affect women. The clinical picture often shifts with hormonal milestones: puberty, pregnancy, postpartum, and perimenopause are all reported trigger points for first symptom onset or disease flares.

The "Silent" Presentation Problem

Women with celiac disease are more likely to present with iron-deficiency anemia, osteoporosis, infertility, or mood disturbances than with the classic diarrhea-and-weight-loss picture that textbooks describe. A 2019 systematic review in Digestive and Liver Disease found that iron-deficiency anemia was present in up to 46% of women newly diagnosed with celiac disease, compared with lower rates in men. This atypical presentation delays diagnosis by an average of six to ten years in women.

Menstrual Cycle Effects on Symptoms

Active celiac disease in reproductive-age women commonly disrupts menstrual regularity. Malabsorption of iron, folate, and zinc disrupts ovarian function and can cause oligomenorrhea, secondary amenorrhea, or heavy menstrual bleeding. If your periods are irregular and you also have unexplained anemia or B12 deficiency, celiac testing belongs in your workup.

A useful framework for women's celiac presentations by life stage:

| Life Stage | Most Common Celiac Clue | |---|---| | Reproductive years | Iron-deficiency anemia not responding to iron supplements, menstrual irregularity | | Trying to conceive | Unexplained infertility, recurrent miscarriage | | Pregnancy | History of prior pregnancy loss, low pre-pregnancy BMI, poor gestational weight gain | | Postpartum | New onset of autoimmune thyroid disease, postpartum depression with GI symptoms | | Perimenopause | Accelerated bone loss, worsening GI symptoms attributed only to hormonal change | | Post-menopause | Osteoporosis with no other explanation, persistent anemia |

Celiac Disease and Conditions That Overlap with Women&apos;s Health

Hashimoto&apos;s Thyroiditis and Autoimmune Thyroid Disease

Celiac disease and autoimmune thyroid disease share genetic risk loci on chromosome 6. A meta-analysis in the Journal of Clinical Endocrinology and Metabolism found that the prevalence of celiac disease in Hashimoto's patients was 3.9%, compared with about 1% in the general population. If your TSH is persistently elevated despite adequate levothyroxine dosing and you also have GI symptoms, your clinician should consider celiac testing. Malabsorption in the proximal small intestine is where levothyroxine is absorbed, so untreated celiac disease can genuinely impair thyroid medication efficacy.

PCOS

The connection between celiac disease and polycystic ovary syndrome is less established, but both conditions involve insulin resistance and chronic low-grade inflammation. Small studies have found a higher-than-expected prevalence of celiac antibodies in women with PCOS. The evidence is not strong enough to recommend routine celiac screening in all women with PCOS, but if you have PCOS plus iron-deficiency anemia or GI symptoms, a celiac panel is reasonable.

Iron and B12 Deficiency

The proximal small intestine (duodenum and upper jejunum) is the primary site of iron, folate, and B12 absorption. These are exactly the areas damaged earliest in celiac disease. If you have been diagnosed with iron-deficiency anemia or B12 deficiency without a clear cause (heavy periods explain iron loss, but not B12 deficiency), a celiac panel should be part of the workup. The American Gastroenterological Association recommends celiac testing in patients with unexplained iron-deficiency anemia.

Osteoporosis and Bone Health

Calcium and vitamin D are also absorbed in the upper small intestine. Women with undiagnosed celiac disease accumulate years of poor calcium absorption, raising fracture risk substantially. A Swedish population study found that women with celiac disease had a 29% higher risk of hip fracture than matched controls. If your DEXA scan shows low bone density at an age or body weight that does not explain it, celiac disease is worth excluding.

Celiac Disease in Pregnancy, Postpartum, and When Trying to Conceive

This section is required reading if you are pregnant, planning a pregnancy, or breastfeeding.

Fertility

Undiagnosed and untreated celiac disease is associated with higher rates of unexplained infertility. A meta-analysis in Reproductive BioMedicine Online reported a prevalence of 3.5% celiac disease in women with unexplained infertility, compared with roughly 0.5-1% in fertile control women. The proposed mechanism involves malnutrition (particularly folate, zinc, and selenium deficiency), hormonal disruption from systemic inflammation, and possibly direct antibody effects on the endometrium.

A strict gluten-free diet in women with celiac disease has been associated with improved fertility outcomes, though the trial data are limited to observational studies.

Pregnancy Outcomes

Active celiac disease during pregnancy is linked to a statistically significant increase in miscarriage, intrauterine growth restriction, preterm birth, and low birth weight. A large cohort study published in Gut followed 1,929 pregnancies in women with biopsy-confirmed celiac disease and found that those on a gluten-free diet had pregnancy outcomes that were not significantly different from the general population. The key message: treatment works, but only if the diagnosis has been made.

Folate deficiency from malabsorption is a direct neural tube defect risk. Women with celiac disease who are trying to conceive should discuss higher-dose folic acid supplementation (5 mg/day rather than the standard 400-800 mcg) with their clinician, particularly if they also have the MTHFR variant.

Screening in Pregnancy

Pregnancy itself can temporarily alter tTG-IgA levels. Some women see a transient rise in antibodies in the first trimester, and others see suppression due to the physiological immune tolerance of pregnancy. If celiac disease is strongly suspected during pregnancy, testing should still proceed, but results should be interpreted alongside clinical history rather than in isolation. Biopsy is generally deferred until after delivery unless symptoms are severe.

Postpartum and Lactation

Celiac disease can first declare itself postpartum, possibly because the immune system rebounds after the tolerance state of pregnancy. Postpartum flares may masquerade as postpartum depression, fatigue attributed to new-parenthood sleep deprivation, or anemia attributed to delivery blood loss.

Regarding breastfeeding: a gluten-free diet in a breastfeeding mother does not deprive the infant of any necessary nutrients. Gluten peptides do transfer into breast milk in small amounts. Some research suggests that early gluten introduction at 4-6 months in at-risk infants while breastfeeding may reduce celiac risk, though this is still an evolving area and parents of high-risk infants should discuss timing with a pediatric gastroenterologist.

Who Should Get a Celiac Panel

Higher-Priority Candidates

You are a higher-priority candidate for celiac testing if you:

• Have iron-deficiency anemia that does not respond to at least three months of oral iron therapy
• Have unexplained B12 or folate deficiency
• Have a first-degree relative (parent, sibling, child) with biopsy-confirmed celiac disease
• Carry a diagnosis of type 1 diabetes, Hashimoto's thyroiditis, or another autoimmune condition
• Have osteoporosis or low bone density without an adequate explanation
• Have experienced recurrent miscarriage or unexplained infertility
• Have chronic bloating, diarrhea, or abdominal pain without a clear GI diagnosis

Lower Yield, But Still Worth Discussing

Women with PCOS and GI symptoms, women with persistent fatigue and a negative thyroid workup, and women with hormonal acne who have tried standard therapies without success may have celiac disease as a contributing factor. The evidence for testing in these groups is weaker, but the test itself is low-risk and inexpensive.

Who Does Not Need Routine Screening

The United States Preventive Services Task Force found insufficient evidence to recommend routine celiac screening in asymptomatic adults without risk factors. If you feel well, have no symptoms, and have no first-degree relative with celiac disease, routine screening is not supported by current evidence.

How to Get Accurate Results: What to Do Before the Test

Keep Eating Gluten

The single most important preparation rule: do not go gluten-free before your blood draw. Your antibodies are produced in response to gluten exposure. Guidelines recommend at least 6 weeks of daily gluten consumption (roughly 2-3 slices of wheat bread per day) before testing. Going gluten-free first is the most common reason for a false-negative panel.

Other Factors That Affect Your Result

• IgA deficiency: Ask your clinician to include a total serum IgA so false negatives from IgA deficiency are caught.
• Immunosuppressive medications: Drugs like corticosteroids or biologics can suppress antibody production and lower tTG-IgA artificially.
• Severe malnutrition: End-stage nutritional depletion may suppress antibody production.
• Testing in children under 2: tTG-IgA is less reliable in this age group; DGP-IgA and DGP-IgG are preferred.

What Happens After a Positive Panel

A positive celiac panel is the beginning of the diagnostic path, not the end. Here is what to expect:

1. Referral to gastroenterology. A gastroenterologist will perform an upper endoscopy with multiple biopsies of the duodenum. This remains the gold standard for diagnosis in adults.
2. Marsh classification. Biopsies are graded from Marsh 1 (increased intraepithelial lymphocytes only) to Marsh 3c (total villous atrophy). Most people diagnosed with celiac disease are Marsh 3a, 3b, or 3c.
3. Gluten-free diet. The only treatment is strict, lifelong gluten-free eating. This means no wheat, barley, rye, or contaminated oats.
4. Antibody monitoring. After starting a gluten-free diet, tTG-IgA should fall and ideally normalize within 12-24 months. Serial tTG-IgA testing every 6-12 months tracks dietary adherence and mucosal healing.
5. Nutrient repletion. Work with a registered dietitian to correct deficiencies in iron, B12, folate, vitamin D, calcium, and zinc. Supplementation needs are highest in the first year after diagnosis.
6. Bone density. Women diagnosed at any age should have baseline DEXA scanning, since years of malabsorption may have silently eroded bone.

What "Lowering" or "Raising" Your Celiac Panel Numbers Means

Patients often search for how to lower or raise their celiac panel. The practical meaning is as follows.

Lowering your tTG-IgA is the goal after diagnosis. The only intervention that lowers celiac antibodies is strict gluten elimination. No supplement, medication, or lifestyle change lowers them independently of diet. A 2014 study in Alimentary Pharmacology and Therapeutics showed that tTG-IgA fell significantly within 6 months of starting a gluten-free diet, with the steepest drop in the first 12 weeks. Slow or incomplete normalization usually indicates continued inadvertent gluten exposure.

Raising your tTG-IgA is not a goal. If your numbers are low or undetectable, that is the desired state after a celiac diagnosis and treatment. If your numbers were never elevated, that is reassuring if you were eating gluten at the time of testing.